临床指南指导医疗保健专业人员采取循证实践。评估指南的影响可以阐明信息的渗透性、相关性、有效性以及与不断发展的医学知识和技术进步的一致性。美国神经外科医生协会/神经外科医生大会肿瘤分会将于 2024 年迎来成立 40 周年，本文回顾了该分会过去十年制定的肿瘤指南，并探讨了它们对其他出版物、专利和信息传播的影响。回顾了六种肿瘤指南类别：低级别胶质瘤、新诊断的胶质母细胞瘤、进行性胶质母细胞瘤、转移性脑肿瘤、前庭神经鞘瘤和垂体腺瘤。引文数据是从 Google Scholar 和 PubMed 收集的。更多在线统计数据（例如社交媒体覆盖范围以及政策、新闻和专利特征）均来自 Altmetric。在线参与度通过网站和 CNS 移动应用程序访问进行评估。自发布以来数据已按时间标准化。 《转移性肿瘤指南》（2019 年）的 PubMed 引用率最高，为每年 26.1 次，网页访问量最高（2019 年 1 月 1 日至 2023 年 9 月 30 日页面浏览量为 29 100 次）。值得注意的是，该指南获得了神经肿瘤学会和美国临床肿瘤学会等伙伴协会的两份认可出版物，内容涉及抗癫痫预防和类固醇使用，并且 X 的覆盖率最高（19.7 次提及/年）。 Google Scholar 上的引用率领先于前庭神经鞘瘤 (Vestibular Schwannoma)（2018 年）。 Mendeley 读数显示无功能垂体腺瘤。新闻、专利或政策出版物以低级别神经胶质瘤为主导，每年 1.5 篇。我们的研究表明，美国神经外科医生协会/神经外科医生大会肿瘤分会指南超出了同行评审出版物中的引用范围，还包括专利、在线参与和向公众传播信息。版权所有 © 神经外科医生大会 2024。 所有保留权利。

Clinical guidelines direct healthcare professionals toward evidence-based practices. Evaluating guideline impact can elucidate information penetration, relevance, effectiveness, and alignment with evolving medical knowledge and technological advancements. As the American Association of Neurological Surgeons/Congress of Neurological Surgeons Section on Tumors marks its 40th anniversary in 2024, this article reflects on the tumor guidelines established by the Section over the past decade and explores their impact on other publications, patents, and information dissemination. Six tumor guideline categories were reviewed: low-grade glioma, newly diagnosed glioblastoma, progressive glioblastoma, metastatic brain tumors, vestibular schwannoma, and pituitary adenomas. Citation data were collected from Google Scholar and PubMed. Further online statistics, such as social media reach, and features in policy, news, and patents were sourced from Altmetric. Online engagement was assessed through website and CNS+ mobile application visits. Data were normalized to time since publication. Metastatic Tumor guidelines (2019) had the highest PubMed citation rate at 26.1 per year and webpage visits (29 100 page views 1/1/2019-9/30/2023). Notably, this guideline had two endorsement publications by partner societies, the Society of Neuro-Oncology and American Society of Clinical Oncology, concerning antiepileptic prophylaxis and steroid use, and the greatest reach on X (19.7 mentions/y). Citation rates on Google Scholar were led by Vestibular Schwannoma (2018). Non-Functioning Pituitary Adenoma led Mendeley reads. News, patent, or policy publications were led by low-grade glioma at 1.5/year. Our study shows that the American Association of Neurological Surgeons/Congress of Neurological Surgeons Section on Tumors guidelines go beyond citations in peer-reviewed publications to include patents, online engagement, and information dissemination to the public.Copyright © Congress of Neurological Surgeons 2024. All rights reserved.